转移性结肠癌的系统疗法:新的前沿
1Division of Hematology and Oncology, Department of Internal Medicine, Columbia University Irving Medical Center, New York, New York.
Clinics in colon and rectal surgery
|April 28, 2025
概括
转移性结肠癌治疗的进展显示,通过生物标志物驱动疗法和组合化疗改善了生存率. 针对无法切除的病例,新的向治疗方法和策略正在出现.
科学领域:
- 在瘤学瘤学.
- 医学瘤学 医学瘤学
- 胃肠道瘤学 胃肠道瘤学
背景情况:
- 在过去的十年中,在改善转移性,不可切除的结肠癌患者的整体存活率方面取得了重大进展.
- 组合化疗仍然是主要的治疗方式,但该领域正在转向生物标志物驱动的方法.
- 针对性疗法的出现提供了新的希望和治疗途径.
研究的目的:
- 审查与结肠癌治疗相关的当前生物标志物.
- 总结一,二,三线治疗转移性,不可切割的结肠癌的护理标准.
- 引入新的治疗策略和正在研究的药物.
主要方法:
- 文献综述,重点关注结肠癌中的生物标志物驱动疗法.
- 对转移性,不可切除的结肠癌的标准护理治疗指南的分析.
- 探索正在进行的临床试验和新兴治疗剂.
主要成果:
- 该审查概述了指导结肠癌治疗决策的关键生物标志物.
- 它详细介绍了当前的一线,二线和三线全身治疗选择.
- 突出显示了有前途的新型向疗法和创新的治疗策略.
结论:
- 转移性,不可切除的结肠癌的治疗越来越个性化,并以生物标志物为导向.
- 组合化疗仍然是基本的,由新兴的向药物补充.
- 对新型疗法的持续研究有望进一步改善患者的治疗结果.
更多相关视频
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
13.6K
07:44Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay
Published on: March 12, 2018
10.0K
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:49Cancer Therapies
7.4K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.4K
01:27Tumor Immunotherapy
397
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
397
02:30Metastasis
5.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K